NovoCure Limited
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $96.2M | $142.3M | $99.8M |
| FY2017 | $97.3M | $113.6M | $78.6M |
| FY2018 | $149.3M | $112.3M | $140.6M |
| FY2019 | $149.4M | $217.8M | $177.3M |
| FY2020 | $429.9M | $476.5M | $234.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $96.2M | $142.3M | $99.8M |
| FY2017 | $97.3M | $113.6M | $78.6M |
| FY2018 | $149.3M | $112.3M | $140.6M |
| FY2019 | $149.4M | $217.8M | $177.3M |
| FY2020 | $429.9M | $476.5M | $234.7M |